Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

NCT02421510 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

782

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Sotagliflozin
DRUG: Sotagliflozin
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]